Papers
2
Total Citations
9
H-Index
2
About
Xi Xiao is a leading urological researcher whose work centers on optimizing surgical outcomes and quality of life for prostate cancer patients. His major contributions lie in the comparative evaluation of robotic surgical techniques, particularly through rigorous meta-analyses that clarify the trade-offs between different treatment modalities. Xiao’s landmark 2025 systematic review and meta-analysis, which has already garnered 5 citations, provides critical evidence on postoperative functional complications and quality of life following robot-assisted prostatectomy versus radiotherapy for localized prostate cancer. This work directly informs clinical decision-making by quantifying patient-centered outcomes. In a complementary 2025 study with 4 citations, Xiao conducted an updated meta-analysis comparing single-port versus multi-port robot-assisted radical prostatectomy, demonstrating superior perioperative efficiency and clinical outcomes for the single-port approach. His research is notable for its methodological rigor and immediate clinical relevance, helping surgeons and patients navigate the evolving landscape of minimally invasive prostate cancer treatment. Xiao’s work is essential reading for urologists and researchers seeking evidence-based guidance on robotic surgical innovations.
Research Focus
Key Achievements
Top Papers
- 1
- 2